188 related articles for article (PubMed ID: 29978518)
41. Improvement of Sclerodermatous Graft-Versus-Host Disease in Mice by Niclosamide.
Morin F; Kavian N; Nicco C; Cerles O; Chéreau C; Batteux F
J Invest Dermatol; 2016 Nov; 136(11):2158-2167. PubMed ID: 27424318
[TBL] [Abstract][Full Text] [Related]
42. Pharmacological inhibition of porcupine induces regression of experimental skin fibrosis by targeting Wnt signalling.
Chen CW; Beyer C; Liu J; Maier C; Li C; Trinh-Minh T; Xu X; Cole SH; Hsieh MH; Ng N; Althage A; Meeusen S; Pan S; Svensson EC; Seidel HM; Schett G; Gergely P; Harris JL; Distler JH
Ann Rheum Dis; 2017 Apr; 76(4):773-778. PubMed ID: 28153829
[TBL] [Abstract][Full Text] [Related]
43. Single-arm, open-label pilot intervention study to investigate an effect of oral 5-aminolevulinic acid plus sodium ferrous citrate on glucocorticoid reduction in patients with adult-onset Still disease: Study protocol for clinical trial (SPIRIT compliant).
Sumiyoshi R; Koga T; Shimizu T; Sato S; Tashiro S; Hosogaya N; Yamamoto H; Kawakami A
Medicine (Baltimore); 2020 Dec; 99(50):e22708. PubMed ID: 33327226
[TBL] [Abstract][Full Text] [Related]
44. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
45. In vivo curative and protective potential of orally administered 5-aminolevulinic acid plus ferrous ion against malaria.
Suzuki S; Hikosaka K; Balogun EO; Komatsuya K; Niikura M; Kobayashi F; Takahashi K; Tanaka T; Nakajima M; Kita K
Antimicrob Agents Chemother; 2015 Nov; 59(11):6960-7. PubMed ID: 26324278
[TBL] [Abstract][Full Text] [Related]
46. 5-Aminolevulinic acid exerts renoprotective effect via Nrf2 activation in murine rhabdomyolysis-induced acute kidney injury.
Uchida A; Kidokoro K; Sogawa Y; Itano S; Nagasu H; Satoh M; Sasaki T; Kashihara N
Nephrology (Carlton); 2019 Jan; 24(1):28-38. PubMed ID: 29068550
[TBL] [Abstract][Full Text] [Related]
47. [ALA-PDT alleviates graft-versus-host disease in mice following allogenic bone marrow transplantation].
Ran HH; Pan KL; Zhang R; Wang YF
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Oct; 8(5):408-12. PubMed ID: 17052403
[TBL] [Abstract][Full Text] [Related]
48. Arsenic trioxide prevents murine sclerodermatous graft-versus-host disease.
Kavian N; Marut W; Servettaz A; Laude H; Nicco C; Chéreau C; Weill B; Batteux F
J Immunol; 2012 May; 188(10):5142-9. PubMed ID: 22491256
[TBL] [Abstract][Full Text] [Related]
49. Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis.
Stenström M; Nyhlén HC; Törngren M; Liberg D; Sparre B; Tuvesson H; Eriksson H; Leanderson T
J Dermatol Sci; 2016 Jul; 83(1):52-9. PubMed ID: 27156795
[TBL] [Abstract][Full Text] [Related]
50. Allograft inflammatory factor-1 is overexpressed and induces fibroblast chemotaxis in the skin of sclerodermatous GVHD in a murine model.
Yamamoto A; Ashihara E; Nakagawa Y; Obayashi H; Ohta M; Hara H; Adachi T; Seno T; Kadoya M; Hamaguchi M; Ishino H; Kohno M; Maekawa T; Kawahito Y
Immunol Lett; 2011 Mar; 135(1-2):144-50. PubMed ID: 21040744
[TBL] [Abstract][Full Text] [Related]
51. Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice.
Pai CS; Khuat LT; Chen M; Murphy WJ; Abedi M
Biol Blood Marrow Transplant; 2017 Jan; 23(1):30-37. PubMed ID: 27815049
[TBL] [Abstract][Full Text] [Related]
52. alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma?
Kokot A; Sindrilaru A; Schiller M; Sunderkötter C; Kerkhoff C; Eckes B; Scharffetter-Kochanek K; Luger TA; Böhm M
Arthritis Rheum; 2009 Feb; 60(2):592-603. PubMed ID: 19180474
[TBL] [Abstract][Full Text] [Related]
53. Targeting of NADPH oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosis.
Dosoki H; Stegemann A; Taha M; Schnittler H; Luger TA; Schröder K; Distler JH; Kerkhoff C; Böhm M
Exp Dermatol; 2017 Jan; 26(1):73-81. PubMed ID: 27576129
[TBL] [Abstract][Full Text] [Related]
54. Combination of 5-aminolevulinic acid and ferrous ion reduces plasma glucose and hemoglobin A1c levels in Zucker diabetic fatty rats.
Hara T; Koda A; Nozawa N; Ota U; Kondo H; Nakagawa H; Kamiya A; Miyashita K; Itoh H; Nakajima M; Tanaka T
FEBS Open Bio; 2016 Jun; 6(6):515-28. PubMed ID: 27239432
[TBL] [Abstract][Full Text] [Related]
55. Combined inhibition of c-Abl and PDGF receptors for prevention and treatment of murine sclerodermatous chronic graft-versus-host disease.
Zerr P; Distler A; Palumbo-Zerr K; Tomcik M; Vollath S; Dees C; Egberts F; Tinazzi I; Del Galdo F; Distler O; Schett G; Spriewald BM; Distler JH
Am J Pathol; 2012 Nov; 181(5):1672-80. PubMed ID: 22940072
[TBL] [Abstract][Full Text] [Related]
56. Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin.
Ohashi T; Yamamoto T
Exp Dermatol; 2015 Sep; 24(9):698-702. PubMed ID: 25959255
[TBL] [Abstract][Full Text] [Related]
57. Sodium Ferrous Citrate and 5-Aminolevulinic Acid Exert a Therapeutic Effect on Endotoxin-Induced Uveitis in Rats.
Otaka Y; Kanai K; Okada D; Nagai N; Yamashita Y; Ichikawa Y; Tajima K
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686331
[TBL] [Abstract][Full Text] [Related]
58. ATX-S10(Na)-PDT shows more potent effect on collagen metabolism of human normal and scleroderma dermal fibroblasts than ALA-PDT.
Takahashi H; Komatsu S; Ibe M; Ishida-Yamamoto A; Nakajima S; Sakata I; Iizuka H
Arch Dermatol Res; 2006 Nov; 298(6):257-63. PubMed ID: 16977444
[TBL] [Abstract][Full Text] [Related]
59. Efficacy and safety of 5-aminolevulinic acid in adult-onset Still's disease: A preclinical study in mice and a pilot study in humans.
Koga T; Sumiyoshi R; Tsuji Y; Kodama K; Endo Y; Furukawa K; Kawakami A
Clin Immunol; 2023 Dec; 257():109846. PubMed ID: 38007033
[TBL] [Abstract][Full Text] [Related]
60. Mast cells in murine graft-versus-host disease: a model of immunologically induced fibrosis.
Choi KL; Claman HN
Immunol Ser; 1989; 46():641-51. PubMed ID: 2488873
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]